School of Medicine
Showing 1-50 of 89 Results
-
Lusine Aghajanova, M.D., Ph.D.
Clinical Professor, Obstetrics & Gynecology - Reproductive Endocrinology & Infertility
BioDr. Aghajanova received her medical degree from Yerevan State Medical University in Armenia, followed by residency in obstetrics and gynecology, then completed PhD in Human Implantation at Karolinska Institute, Stockholm, Sweden, followed with embryology training at Karolinska Institute, with an Internship in Austria.
She continued her research as a postdoctoral fellow at the University of California San Francisco.
Subsequently, Dr. Aghajanova completed residency in Obstetrics and Gynecology at Baylor College of Medicine, Houston, Texas and at UC San Francisco. She proceeded then with subspecialty fellowship training in Reproductive Endocrinology and Infertility at UC San Francisco. Dr Aghajanova joined Stanford in 2017. She is a respected researcher in the field of endometrial receptivity, implantation and endometriosis, as well as access to reproductive care. She is the Program Director for REI fellowship at Stanford Medicine. She is also Director of Thirds Party Reproduction at Stanford Fertility and Reproductive Care.
Dr. Aghajanova speaks Russian and Armenian and is very well published with over 90 peer-reviewed publications as well as numerous other oral and poster presentations and is a professional peer-reviewer for over 12 journals, including Nature Journals and leading journals in field of reproduction.
Dr.Aghajanova enjoys spending time with her husband and children, and traveling. -
Meghali Aich
Postdoctoral Scholar, Neonatal and Developmental Medicine
BioMy research interest lies in understanding how environmental factors contribute to neurodevelopmental disorders and translating those insights into therapies. Aligned with this, my current research in Dr. Anca Pasca’s lab at Stanford focuses on how reductive stress associated with maternal metabolic syndrome affects fetal brain development.
-
Jacob S. Ballon, MD, MPH
Associate Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
BioJacob S. Ballon, M.D., M.P.H. specializes in the treatment of people with psychotic disorders including schizophrenia. He is the Co-Director of the INSPIRE Clinic at Stanford which provides interdisciplinary care for people experiencing psychosis. He is also the Associate Chair for Patient Services and co-Division Chief for General Adult Psychiatry and Psychology in the Department of Psychiatry. Dr. Ballon completed his residency at Stanford in 2009 and a Schizophrenia Research Fellowship at Columbia University in 2011.
Dr. Ballon's research focuses primarily in clinical trials of new medications for the treatment of schizophrenia. He further maintains an interest in understanding the connections between the brain and the rest of the body as relates to the manifestation and treatment of people who experience psychosis. He works closely with a diverse group of researchers throughout the university and technology community to investigate these connections. He has participated in numerous projects investigating the metabolic implications of schizophrenia and of psychiatric medication including the association of antipsychotic medication with weight gain and insulin resistance.
INSPIRE is an innovative interdisciplinary client-centered resource providing respectful evidence-based care to support people to achieve meaningful recovery from psychosis through collaborative partnership with individuals and their families while advancing knowledge and training for a new generation of providers. With a recovery-oriented philosophy, the clinic provides an array of services including psychopharmacology, psychotherapy, and psychosocial evaluations. As a research clinic, they are focused on collaborating with multiple disciplines throughout the university to conduct clinical and basic science research including functional imaging, clinical trials, basic pathophysiology, and genetics. -
Che-Hong Chen
Senior Research Scientist - Basic Life, Chemical and Systems Biology Operations
Current Role at StanfordSenior Research Scientist
CEO, International ALDH2 STAR Research Consortium
Director of China, Singapore, and Taiwan Outreach, Center for Asian Health Research and Education Center -
Hansen Chen
Instructor, Neurosurgery
Current Research and Scholarly InterestsTranslational Stroke Research; Blood-Brain Barrier, Brain Immune Responses
-
Atman Desai, MD
Clinical Professor, Neurosurgery
Current Research and Scholarly InterestsThe Stanford Spine Artificial Intelligence Laboratory develops data-driven technologies to improve diagnosis, surgical planning, and outcomes in spine care. Our research spans predictive modeling, computational imaging, spinal oncology, digital surgery, and real-world functional assessment using wearables. By integrating clinical, imaging, and functional data at scale, we aim to deliver clinically meaningful, patient-centered innovations for complex spinal disease.
-
Sebastian Duno-Miranda
Postdoctoral Scholar, Biochemistry
BioI started my training as a biologist at the Universidad Central de Venezuela (UCV) and the Instituto Venezolano de Investigaciones Cientificas (IVIC). My Licentiate thesis degree advisor was Dr. Raúl Padrón, whom with I studied the structure and function of tarantula muscle, a key non-conventional animal model to understand muscle function in humans. Next, I would move to pursue doctoral studies at the University of Vermont, under Dr. David M. Warshaw supervision, studying the molecular mechanics of human cardiac myosin, the motor responsible for powering up the contractions of the human heart, the effect of multiple cardiomyopathy mutations, and the application of machine learning to enhance myosin single-molecule data analysis. Now, I've joined the lab of Dr. James Spudich at Stanford University, to continue pushing the frontiers of knowledge regarding the molecular physiology of human myosins in the context of heart disease. For more details please see https://duno-miranda.org
-
Yanan Feng
Sr. Research Scientist - Basic Life, Genetics
Current Role at StanfordSenior Research Scientist, Department of Genetics, Dr. Stanley N. Cohen's lab
-
Daiana Fornes
Life Science Research Professional 3, Obstetrics Anesthesiology
BioDaiana Fornes is a postdoctoral scholar at Stanford University, supported by a Maternal & Child Health Research Institute (MCHRI) Postdoctoral Fellowship. Her research centers on reproductive biology and pregnancy disorders, with a particular focus on uterine contractility, preterm labor, and uterine atony. She investigates calcium signaling pathways, including the role of TRPV4 ion channels, to identify novel therapeutic strategies aimed at improving maternal health outcomes.
Daiana earned her PhD from the University of Buenos Aires, where she studied metabolic alterations during pregnancy and their effects on fetal development. Her training has provided her with a strong foundation in translational research, with extensive experience in experimental design, molecular biology, and the analysis of signaling pathways. -
Fumiaki Ikeno
Program Director (U.S) Japan Biodesign, Stanford Biodesign, Medicine - Med/Cardiovascular Medicine
BioProgram Director (U.S) Japan Biodesign, Stanford Biodesign
Researcher Cardiovascular Medicine, Stanford University
Faculty of Japan Reach, CARE (Center for Asian Health Research and Education) , Stanford University
Co-Director of Asia, SPARK Global, Stanford SPARK , Stanford University
Dr. Ikeno is a Researcher, Cardiovascular Medicine, Stanford University. In this role, he is responsible for pre clinical studies including GLP for medical devices and also regenerative medicines for cardiovascular diseases. Currently, he is devoting himself to the international regulatory project between Japan and the United States, also known as "Harmonization by Doing", whose focus is to collaborate with regulatory agencies such as FDA, PMDA/MHLW, academia and industries for improving the regulatory process in the 2 largest medtech markets. Dr. Ikeno also devoted himself to found Japan biodesign program which is a collaborative program with University of Tokyo, Osaka University, Tohoku University, Japan Federation Medical Device Association, Ministry of Education Japan and Stanford biodesign program. Currently, Dr. Ikeno serves as the Program Director (US) for Japan Biodesign. Dr. Ikeno is co-founder and board member of US-Japan MedTech Frontier which is a non-profit cooperate to make a trans-pacific eco-system of medical device between Japan and USA.
After 9 years clinical practice as an interventional cardiologist and Family Doctor in rural areas of Japan, Dr. Ikeno came to Stanford as a Researcher and completed his Biodesign Certificate Program. Being part of the ecosystem in Silicon Valley, Dr. Ikeno participated in more than 200 medtech projects and 50 GLP studies as well as in the analysis of clinical trials for cardiovascular medicine (BARI2D, FAME, ReOPEN etc). His other academic consortium projects include Peripheral Academic Research Consortium, Global Consensus Working Group of Optical Coherence Tomography, and Japan-US consensus document for the treatment of critical limb ischemia.
Over the last decade, Dr. Ikeno has served as an advisor for medical device industries and currently serves as a chief medical officer of an incubation fund specific for medtech (Medventure Partners, Inc, Tokyo) as a spin-off from Innovation Network Corporation of Japan (INCJ) that is the largest government and private partnership fund in Japan. He is also serving as a chair of cardiovascular working group of APAN (Asian Pacific Advanced Network) that contributes the remote education, research activities, and tele-health using a specialized internet network. Dr.Ikeno is also serving as consulting faculty/lecturer roles in several universities in Japan including University of Tokyo, Osaka University, Tsukuba University etc. Dr. Ikeno has authored over 70 peer reviewed publications and textbooks and has been invited to lecture at international medical conferences. Dr. Ikeno is a council member of U.S.- Japan Council which is a non-profit organization by Japanese American. He is serving as a mentor for START-X MED which is an accelerating program for Stanford related entrepreneurs in medical fields.
Contact Information
Falk CVRC CV007
300 Pasteur Drive
Palo Alto, CA 94305-5406 -
Kathy Johnson
Executive Administrator, SPARK at Stanford
Current Role at StanfordProgram Administrator, SPARK at Stanford
Executive Admin to:
Daria Mochly-Rosen, Professor
Kevin V. Grimes, Professor - Teaching
Department of Chemical & Systems Biology -
Sharada Kalanidhi
Director of Data Science, Biochemistry - Genome Center
Current Role at StanfordParaphrasing the mathematician Alexander Grothendieck: the essential thing is to pose problems in the right framework.
Sharada is developing a new field, Mathematical Medicine, which applies pure mathematical frameworks to genomic and multi-omic data for quantitative, personalized diagnosis. This approach explores alternatives to prevailing cohort-based statistical paradigms, particularly in complex clinical cases that have resisted standard methods.
After more than a decade of research and close collaboration with biochemists at the Stanford Genome Technology Center (Dept. of Biochemistry), Sharada concluded that the mathematics currently used for multi-omic diagnosis is inadequate for the level of biological and clinical complexity being attempted. Her conclusion echoes the perspective of the mathematician Mikhail Gromov: “This area does not yet exist. It will have to be invented.” Mathematical Medicine represents one possible construction of such an area. This approach is aligned in spirit with the philosophy of the late mathematician Jim Simons: "We don't start with models. We start with data. We don't have any preconceived notions." Mathematical Medicine lets the data speak for itself.
This field is focused on the development of an intermediate translation layer between cohort-based statistical models and individualized multi-omic diagnosis and clinical decision-making. Without this mathematical layer, the clinical adoption of multi-omic data- particularly for complex cases- has been limited. As a result, many complex, multi-system conditions remain undiagnosed or misdiagnosed for long periods, delaying effective treatment and, in some cases, allowing disease processes to worsen. Additionally, what is learned from rare and extreme cases proves highly informative for the rest of the population.
Further information on this field, including opportunities for early philanthropic partnerships, is available at: https://mathmed-2026.web.app/ -
Devanish Narasimhasanth Kamtam
Visiting Instructor, Cardiothoracic Surgery - Thoracic Surgery
BioDr. Devanish Kamtam is a Visiting Instructor in the Division of Thoracic Surgery at Stanford University, working in Dr. Joseph Shrager's lab. His research focuses on surgical AI, AI in medical imaging, and clinical outcomes in Thoracic Surgery. He completed his MBBS at Gandhi Medical College, Hyderabad and MS in General Surgery at AIIMS New Delhi.
-
Jeewon Sylvia Kim
Program Manager, SPARK at Stanford
Current Role at StanfordProgram manager for SPARK Translational Science Program overseeing educational seminar series, managing projects and facilitating SPARK global operations.
-
Bruce Koch, Ph.D.
Director of High-Throughput Screening, Sarafan ChEM-H
Current Role at StanfordDirector, ChEM-H/CSB High Throughput Screening Group
Staff Lead, IMA HTS Module
Adviser to the SPARK Program -
Marc Leon (aka Hongliang Liang) MD, PhD
Clinical Assistant Professor, Cardiothoracic Surgery
BioMarc Leon (also known as Hongliang Liang), M.D., Ph.D., previously served as Chief Surgeon, Associate Professor of Cardiovascular Surgery, and Director of the Division of Coronary Artery Surgery at Xijing Hospital in Xi'an, China. Currently, he is a Clinical Assistant Professor in the Department of Cardiothoracic Surgery at Stanford Hospital. Dr. Leon is a surgeon member of the Society of Thoracic Surgeons (STS), the International Society of Heart and Lung Transplantation (ISHLT), and the Chinese American Academy of Cardiology (CAAC). His clinical and research expertise includes the surgical management of cardiopulmonary failure, heart valve disease, and ischemic heart disease, along with the application of stem cell therapy for myocardial infarction. Additionally, Dr. Leon is actively engaged in exploring the application of artificial intelligence in the field of cardiovascular diseases.
-
Joanna E. Liliental, PhD
Director, TRAM, M-TRAM, TASC, Med/TRAM
Current Role at StanfordExecutive Director, Master's in TRAM (M-TRAM)
https://med.stanford.edu/tram/masters-program.html
Director, Translational Applications Service Center (TASC)
http://tasc.stanford.edu
Associate Director, Translational Research and Applied Medicine (TRAM) Program
http://tram.stanford.edu
Senior Research Scientist, Stanford School of Medicine
Instructor of University Courses: MED221,MED121, MED212A
Member, Stanford Cancer Institute -
Xin Liu
Basic Life Science Research Scientist, Genetics
BioXin Liu is a postdoctoral Research Scientist in the Department of Genetics at Stanford University. Xin holds a PhD in Chemistry from the University of Michigan, Ann Arbor. Her basic research interests include RNA and protein biochemistry, enzymology, cancer immunology, and autoimmune disease. She has published papers in several prestigious journals in the field of biochemistry, including Nature Communications, Journal of American Chemical Society, and Nucleic Acids Research. The highlight of her multidisciplinary research includes the development of high-throughput enzymatic methods to discover anti-microbial agents and to reveal mechanisms behind human mitochondrial diseases, as well as innovative applications of genome engineering and machine-learning to decode principles of RNA editing in human cells. Her current research focuses on the mechanistic study of innate immune pathways.
